Skip to content

13F-HR filed by AJU IB Investment Co., Ltd.

AJU IB Investment Co., Ltd. filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-07-10, with 8 holding rows worth $91,889,533.

Accession
0001140361-25-025427
Filed
2025-07-10
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2025

A holdings report, 8 entries on the cover page, a total value of $91,889,533 stated on the cover page (in dollars after the unit check, H1), rows summing to $91,889,533 with VALUE read as dollars as filed, 13F file number 028-21185. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ARCELLX INC COMMON STOCK03940C100Stock1,047,557$68,981,628dollars as filed
KYMERA THERAPEUTICS INC501575104COM457,059$19,946,055dollars as filed
SEER INC81578P106COM CL A816,375$1,747,043dollars as filed
Xilio Therapeutics Inc.98422T100COM667,742$453,998dollars as filed
CARISMA THERAPEUTICS INC14216R101COM718,332$281,299dollars as filed
RALLYBIO CORP75120L100COM754,678$255,081dollars as filed
SUTRO BIOPHARMA INC869367102COM175,000$124,933dollars as filed
RAPT THERAPEUTICS INC75382E109COM12,437$99,496dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-25-025427this filing2025-07-10acceptance time not in the bulk data set